Absci Corporation — Quarterly Cash Flow (NASDAQ:ABSI) | MetaTrader

Open full chart

Financials

Overview Estratto Conto Statistics Dividends

Quarterly Annual

Total assets 235.23 M213.61 M232.45 M209.89 M244.99 M Total liabilities 33.9 M34.48 M33.65 M36.52 M34.65 M Total equity 201.34 M179.13 M198.8 M173.37 M210.34 M Total liabilities & shareholders' equities 235.23 M213.61 M232.45 M209.89 M244.99 M Total debt ————— Net debt —————

Notizie

The Genesis Mission Has a 270-Day Timeline – And You're Already Late

H.B. Fuller, Caledonia Mining And Other Big Stocks Moving Lower In Thursday's Pre-Market Session - Absci (NASDAQ:ABSI), Buckle (NYSE:BKE)

Absci Corporation (ABSI) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

Morgan Stanley downgrades Absci stock on TL1A setback and higher risk profile

Absci Corporation (ABSI) Discusses ABS-201 Program and Clinical Approach for Androgenetic Alopecia Transcript

L’anticorpo ABS-201 di Absci mostra risultati promettenti per il trattamento della ricrescita dei capelli

Absci’s ABS-201 antibody shows promise for hair regrowth treatment

These 3 Under-the-Radar Stocks Have Triple-Digit Upside Potential – 12/5/2025 - TipRanks.com

ABSI Stock Up on Initiating Dosing in Androgenetic Alopecia Study

Absci somministra il primo vaccino nella sperimentazione di fase 1/2a dell’anticorpo per la caduta dei capelli

Absci doses first volunteers in phase 1/2a trial of hair loss antibody

Miss These Genesis Mission Stocks, and You'll Regret It for a Decade